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Abstract
The NADPH-dependent nitrile-oxidioreductase, QueF is the only known enzyme capable of reducing a
nitrile group to an amine. This ability makes it an attractive alternative to conventional industrial nitrile
redution. Understating how QueF binds NADPH may lead to the development of an enzyme capable of
using the less expensive reductive cofactor NADH. A cofactor docking model indicates that key residues,
Q60 and Y21, interact with the ribose phosphate moiety unique to NADPH. Mutants of these residues
(Q60A, Q60N, Q60E, Y21A and Y21F) were developed for steady-state kinetic analysis. Modification to
either residue resulted in a decrease in binding and catalytic activity when using NADPH as a hydride
source. Q60E had the greatest reduction in activity (0.45% of WT). There appears to be both charge and
steric factors involved in direct cofactor binding. Neither WT or mutant enzymes were able to utilize NADH
as a reductive cofactor to any observable extent.
Background
Transfer ribonucleic acids (tRNAs) are the adaptor molecules that allow for accurate translation of
messenger RNA (mRNA) to peptide. tRNA effectively translates genetic information to peptide by
matching the correct amino acid to the genetic information carried by the mRNA in the ribosome1. The
typical tRNA molecule is L-shaped with an acceptor stem (yellow, Figure 1 left) and an anticodon loop
(black, Figure 1 left) on either end. Translation fidelity relies on two important steps. The first is the
charging of the particular tRNA with the correct amino acid, accomplished by aminoacyl tRNA synthetases
(aaRS)2. The second is the matching of the anticodon, the section of RNA that complements the mRNA
codon, to the mRNA during translation. There are 20 amino acids that are encoded in the mRNA by 61
distinct triplet codons along with three codons that encode the end of a translation template, known as a
STOP codon3. This discrepancy between the number of codons and anticodons is referred to as the
degeneracy of the genetic code and is allowed largely by chemical modification to nucleotides at positions
34 and 37 of the tRNA (Figure1 right). Position 34 is known as the wobble position, coined by Francis Crick
in 1966. Certain nucleotides in the wobble position have the ability to pair with multiple non-cognate
bases. Modifications to the nucleotides in the wobble position can restrict or expand the number of bases
with which they can pair4. One such nucleotide located in position 34 is the hypermodfied nucleoside 2Amino-5-[[[(1S,4S,5R)-4,5-dihydroxy-1-cyclopent- 2-enyl]amino]methyl]- 7-[(2R,3R,4S,5R)- 3,4-dihydroxy5-(hydroxymethyl)- 2-tetrahydrofuranyl]-1H-pyrrolo[3,2-e]pyrimidin-4-one, queuosine. Queuosine is
found in tRNAs with the GUN anticodon consensus sequence (tRNAasp, tRNAasn, tRNAhis, tRNAtyr) and serves
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as a structurally constraining base for tRNA codon loop flexibility. Queuosine is an essential micronutrient
obtained by eukaryotes from diet or gut bacteria5,6.

Figure 1: Two common models for describing tRNA structure. tRNA secondary structure displaying the locations of common
nulcotide modifications(right). tRNA secondary structure and tertiary structure(left).
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member of the Tunneling-fold (T-fold) super family. T-fold proteins bind substrates belonging to purine
and pterin families. Their monomers consist of two alpha helicies layered onto the concave side of a four
strand antiparallel beta sheet. Multiple monomers come together to form a barrel and two barrels
combine head on to form the final multimeric tunnel9. The number of individual domains varies within
the T-fold family, and size exclusion studies and X-ray crystal structures have shown QueF to be a
homodecamer10,8.

Figure 3: QueF’s role in the queuosine bacterial biosynthetic pathway.

Figure 4 Reaction mechanism of the reduction of PreQ0 by QF. His96 and Asp62 act as proton donors/acceptors and Cys55 forms
the thioimide intermediate with the nitrile group in the first step of the reaction.
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Application
Conventional industrial nitrile reduction involves hydrogenation over a metal catalyst or by metal hydride
reduction11,12. Enzymes have the ability to operate in an aqueous environment at physiological
temperature and pressure. To satisfy increasing green chemistry standards, the demand for biocatalysts
in product synthesis, extraction, purification and waste treatment is increasing13. Relaxing cofactor
specificity is important to the use of QueF as a biocatalyst. NADPH and NADH are identical molecules aside
from the presence of a phosphate group at the 2’ position of the ribose ring that carries the adenine
moiety in NADPH. NADPH costs over $10,000/mmol where as NADH costs near $380/mmol (Sigma 2015).
This high cofactor price can be further reduced by developing NADH regenerative systems to be used in
parallel with the catalyst14.
Methods for engineering an enzyme for industrial use typically include directed evolution, rational design
or a combination of the two15. Directed evolution mimics the process of evolution by introducing
mutations and selecting variants with the desired function by application of a selective pressure. This
method can be performed in vivo and in vitro. Rational design involves logically altering the structure of a
protein through the site specific change in identity of target amino acid residues in order to alter the
characteristics of the enzyme. Rational design was the method chosen for altering cofactor specificity in
this project.
Experimental Design
Analysis of QueF cofactor docking models suggests an asymmetrical interaction between the decamer and
NADPH (Figure 4). This interaction is comprised of the cofactor binding in the crease formed by three of
the ten subunits, the nicotinamide group of NADPH positioned near the active site. Residues Q60 and Y21
appear to play an integral role in NADPH specificity. Q60 and Y21 of one subunit appear to interact with
the 2’-phosphate of NADPH while the same residues of an adjacent subunit appear to interact with the
2’-hydroxyl of the nicotinamide ribose. This presents a unique challenge in rational design, as where it
would be advantageous to alter the interaction at the site of the phosphate, a change here may also alter
interaction at the ribose. Site directed mutagenesis and subsequent steady state kinetic analysis will be
utilized to determine the residue’s function in relation to cofactor binding and specificity. Q60 and Y21
will be mutated to alanine residues to establish their importance in cofactor binding. The residues will
then be changed to amino acids with slightly different steric and electronic qualities (Q60A, Q60E, Q60N,
Y21A, Y21F).
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Figure 5 QueF substrate docking model.

Altering the sequence of amino acids within a protein can have a number of effects on its structure. The
mutation can cause the protein to miss-fold, distorting the global structure of the monomer. This
distortion can cause the protein to aggregate or prevent the mutant from otherwise forming the
homodecamer, rendering it incapable of performing catalysis. Mutations may also distort the substrate
binding pocket which can either affect substrate binding or the subsequent thioimide formation. Finally,
the mutation can distort the cofactor binding pocket and alter cofactor binding or specificity.
To insure each mutant can still form a homodecamer their ability to bind substrate and form thioimide
was assessed. The ability to form a thioimide bond with substrate can be used to confirm that the
quaternary structure is intact as the active site is comprised of four monomers, two from each barrel.
Inability to form thioimide indicates either the substrate binding pocket has been disrupted or the
monomers cannot assemble to form the homodecamer. Steady state kinetics analysis was used to
determine the effect of the mutation on the the enzymes ability to bind the cofactor as well as its ability
to perform the necessary chemistry to carryout the reaction. In addition to NADPH turnover assays, all
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mutants were subject to NADH turnover assays to determine if substrate specificity had been altered by
the mutation.
Methods and Materials
General
Olgionucleotide synthesis was carried out by Integrated DNA Technologies, and sequencing was
conducted by the Core Sequence Facility of Oregon Health and Science University. Protein concentrations
were determined by UV-Vis spectroscopy on a Cary 100 Bio UV-Visible spectrophotometer, extinction
coefficients were generated with Expasy ProtParam and confirmed by Bradford assay16,17.
Growth conditions
Cell cultures were grown at 37°C in LB with kanamycin (50ug/ml).
Mutagenesis-Transformation
Site-directed mutagenesis was conducted using the Quick Change Mutagenesis Kit II (Agilent
Technologies)18. Plasmids were transformed into NovaBlue (Novagen) competent cell for plasmid
production, confirmed by Sanger sequencing and transformed into BL21 (Novagen) competent cells
for protein over-production.

Table 1 List of mutant primers used
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Protein production-purification
Cultures of wild type and mutant QF protein were grown for eight hours to an A600 of 3-4. Cells were
pelleted (5Kg x 15min) and resuspended in an equivalent volume of media. Following 30-60 minutes of
resuspension the cells were induced at a final concentration of 1 mM IPTG for four hours.
Post induction cells were harvested by centrifugation (10000g for 20 mins) and resuspended in
purification buffer (100 mM Tris-HCl pH 8.0, 100 mM KCl, 2 mM ß-mercaptoethanol) supplemented with
with 1mM PMSF and 250 µg/mL lysozyme to a final concentration of 250 g/mL. The resulting solutions
were centrifuged (20Kg x 20min) and the supernatant applied to prequilibrated 5ml Ni-NTA (Qiagen)
columns. Once loaded, the column was washed with 10CV purification buffer + 1 mM PMSF, 10CV
purification buffer +20 mM imidazole, and the protein was eluted with 5CV purification buffer +200 mM
imidizole. The protein was concentrated and the imidazole was removed from the elution fraction by
dialysis (SnakeSkin dialysis tubing) against purification buffer, and stored at -80°C. Glycerol was added to
50% of the purified protein.
Turnover assays and relative activity
Consumption of NADPH was measured by loss of absorbance at 340 nm (ε=6220 M-1cm-1). Reaction was
carried out at 37°C in 100 mM potassium phosphate (pH 6.5), 50 mM KCl, 20 mM MgCl2 and 1 mM DTT.
Wild type (WT) (200 nM) and mutant enzymes (20 µM) were incubated with 100 µM PreQ0 for two
minutes. Reaction was initiated with 180 µM NADPH and monitored for 10 minutes.
Thioimide formation
The thioimide bond forms a unique chromophore centered at 376 nm. Reaction mixtures were scanned
between 230 and 420 nm to determine the extent of bond formation. Assay conditions were 100 mM
phosphate (pH 6.5), 50mM KCl, 20 mM MgCl2 and 1mM DTT. Enzyme at 20 µM was saturated with 100
µM PreQ0.
NADH turnover assays
Consumption of NADH was measured by loss of absorbance at 340 nm (ε=6220 M-1cm-1). Reaction was
carried out at 37°C in 100 mM potassium phosphate (ph 6.5), 50 mM KCL, 20 mM MgCl2 and 1 mM DTT.
Wild type (WT) (200 nM) and mutant enzyme (20 µM) were incubated with 100 µM PreQ0 for two minutes.
Reaction was initiated with 180 µM NADH and monitored for 10 minutes.
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Steady-state kinetic analysis – NADPH
Reaction mixtures of 150 µL were comprised of 100mM phosphate (pH 6.5), 50mM KCl, 20mM MgCl2, 1
mM DTT, 400 nM WT enzyme (800 nM mutant), 20 µM PreQ0 and variable NADPH (10-200 µM). Reactions
were initiated by adding 10 µL substrate mix (PreQ0 and NADPH) to 140 µL of enzyme mix (buffer, KCl,
MgCl2, DTT). Both solutions were pre incubated to 37°C for 5 min prior to mixing by pipette in a quartz
cuvette. The reaction was monitored at 340 nM for 15 minutes and held at 37°C. Experiments were run
in triplicate. Background oxidation rates of NADPH were monitored using final reaction mixtures minus
enzyme. The rate of NADPH oxidation (Figure 6) were fit to a standard Michaelis-Menten curve (Eqn 1)
(Figure 7) with KaleidaGraph software. Error for kcat and kcat/Km values was calculated using standard
error propagation methods.
𝜈=

#$%& '
($ ) '

Equation 1

Results

Figure 5 Thioimide formation of WT and mutant QueF

T21F, Q60N, Q60E and WT were able to form a thioimide bond (376 nm) with PreQ0. C55A, lacking the
nucleophilic cysteine residue was unable to form thioimide and was used as a control.
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Table 2 NADH oxidation by QueF WT and mutant

Under saturating conditions of PreQ0, working with in the limits of the NADPH assay and an enzyme
increase 12.5 fold, neither WT or mutant enzymes showed any reductive activity under the presence of
NADH. The NADH oxidation rates for each enzyme are available in Table 2.

Table 3 Kinetic parameters of WT and mutant QueF
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Figure 6 NADPH oxidation data used to determine reaction rates at different cofactor concentrations
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Figure 7 Michaleis-Menten curve comparison of QueF WT and mutant enzymes. Full Michaelis-Menten curves available in
supplemental figures

𝑘+,- =

#$%&
[/]1

Equation 2

Despite not having discrete on and off rates we can use the Km to approximate the Kd. The kcat was
determined using Equation 2. Q60A Km is 5.7 times WT and has a kcat 59% of WT, indicating a decrease in
cofactor affinity and reduction in the rate of catalysis. Q60N Km is 1.95 times WT and has a kcat 26% of
WT, indicating an affinity for cofactor greater than Q60A but less than that of WT and a rate of catalysis
lower than Q60A and WT. Q60E activity was too low to yield any kinetic data from this experiment.
However, under enzyme concentrations 62.5 times higher (25 µM) a rate 4 times slower that WT was
observed yielding a 250-fold decrease in activity. Y21A Km is 3.06 times WT and has kcat 57% of WT
indicating a decrease in cofactor affinity and reduciton in the rate of catalysis. Y21F Km is 1.39 times WT
and has kcat 54% of WT, indicating a lesser reduction of affinity for cofactor than in Y21A and a similar
decreased rate of catalysis.
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Discussion
NADH turnover assay
No mutants were able to utilize NADH as a cofactor for PreQ0 reduction. This is in contrast to the
hypothesis that residues Q60 and Y21 played a specific, distinct role in cofactor specificity. The inability of
neither WT or mutant QueF may implicate that these residues interact with the phosphate moiety to
stabilize and position NADPH to allow for proper hydride transfer.
Steady state kinetic analysis
The kcat can be used to represent the catalytic velocity of the enzyme under ideal, saturated conditions.
Individual on and off rates (Figure 7) cannot be determined using steady-state kinetic analysis. Despite
not having discrete on and off rates we can use the Km to approximate the Kd. The Kd being the ratio of
the on and off rates of the ES complex, in this case the ES+NADPH complex. The lower the Kd, here the
Km, the higher the enzyme’s affinity for the substrate. The ratio of kcat/Km is a measure of catalytic
efficiency, a fast enzyme and or one that can bind substrate at low concentrations will be a more efficient
enzyme and will there have a larger ratio of kcat/Km. Although the docking model shows targeted residues
do not directly interact with PreQ0 binding, without steady-state kinetic analysis of PreQ0 binding we
cannot claim that the mutated residues do not have any concurrent effect on PreQ0 interaction.

Figure 8 QueF kinetic scheme

At the time of discovery, initial characterization determined the WT Km for NADPH to be 36µM and the
kcat to be 0.6 min-1 (100mM Hepes pH 7.5, 1 mM DTT, 50-100 mM KCl at 30°C).19 A second characterization
of WT after metal binding studies showed the Km and Vmax to be 19.2±1.07 µM and 0.69±0.02 min-1,
respectively (100 mM TRIS pH 7.5, 100 mM KCl, 1mM DTT 20 µM PreQ0, 0.776 µM WT QueF for 120s at
30°C)7. Both assessments used the continuous UV-vis assay employed in this experiment. The disparity
between the rates achieved in this experiment, Km: 58.21±10.87 µM and kcat: 1.89±0.38 min-1, compared
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to those of past papers can be attributed to the different conditions, mainly the pH of the reaction buffer.
Studies following the first two characterizations and preceding this experiment determined optimal
enzyme activity proceeded at pH 6.5.
Q60A, having essentially all steric and electric influence eliminated had a much larger Km, nearly 6X of WT
and it’s kcat was 59% of WT. This is supports the relationship posed by the docking model that Q60 has a
role in coordinating cofactor binding/positioning. The decrease in kcat may be a product of diminished
ability to position the substrate by interaction with the 2’OH of the ribose on the subunit proximal to the
active site.
The Q60N mutant would draw the amide side-chain towards the protein backbone. Consistent with the
hypothesis, the Km was greater than WT but less than Q60A, indicating an affinity for cofactor somewhere
in between WT and the alanine mutant. Interestingly, the kcat, at 26% of WT, was lower than that of the
alanine mutant. This may indicate that Q60 may play an important role in positioning the NAPDH
appropriately for hydride transfer. If the R-group of glutamine acts as a positive cup to cradle the
negatively charged phosphate, then the shorter R-group of asparagine may position the nicotinamide
moiety unfavorable, thereby preserving the affinity for substrate yet reducing the overall catalytic rate.
The Q60E mutant may be the most important in supporting the hypothesis that Q60 interacts with the
cofactor phosphate. With 250X less activity than wild type its kinetic parameters were unable to be
experimentally derived. Such a reduction in activity may be attributed to the change in the side chain
function group from an amide to a carboxylate. This strong negative charge of the side chain and the
negative charge of the phosphate group would likely repulse each other, making docking of the cofactor
unfavorable and thereby nearly eliminating its ability to bind cofactor and perform catalysis. Thioimide
forming studies eliminate the possibility that the Q60E mutation impacted the global structure of the
enzyme since PreQ0 binding is essentially unperturbed.
The kinetic data for Y21A and Y21F supported the hypothesis that they have some affect on cofactor
docking and binding. The greater the deviation from the tyrosine side-chain structure the higher the Km,
possibly revealing the steric importance of Y21 in binding/docking NADPH. The kcat of the alanine and
phenylalanine mutants were similar at 54% and 57% of WT, respectively. This decrease in kcat may be due
to decreased unfavorable positioning of the substrate.
This data provides in vitro support that Q60 and Y21 effect cofactor binding, if not in cofactor scpecifcity
than in positioning of cofactor for catalysis of PreQ0 to PreQ1. Future studies should include PreQ0 kinetic
14

analysis of Gln60 and Tyr21 mutants to determine if these residues impact substrate binding rates.
Transient kinetic studies of NADPH and NADH binding in WT and mutants may further elucidate the role
of these residues.
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Additional Figures

Figure 9 Q60A saturation curve

Figure 10 Q60N saturation curve
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Figure 11 WT saturation curve

Figure 12 Y21A saturation curve
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Figure 13 Y21F saturation curve
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